Bleeding Symptoms of Carriers of Hemophilia A and B

This study has been completed.

Sponsor:

Information provided by:

Sahlgrenska University Hospital, Sweden

ClinicalTrials.gov Identifier:

NCT01029808

First received: December 9, 2009

Last updated: July 19, 2011

Last verified: July 2011

History of Changes

Tracking Information
First Received Date ^ICMJE	December 9, 2009
Last Updated Date	July 19, 2011
Start Date ^ICMJE	December 2009
Primary Completion Date	Not Provided
Current Primary Outcome Measures ^ICMJE (submitted: December 9, 2009)	Bleeding tendency in carriers of severe and moderate haemophilia compared to a control group. [ Time Frame: Five years ] [ Designated as safety issue: No ]
Original Primary Outcome Measures ^ICMJE	Same as current
Change History	Complete list of historical versions of study NCT01029808 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE	Not Provided
Original Secondary Outcome Measures ^ICMJE	Not Provided
Current Other Outcome Measures ^ICMJE	Not Provided
Original Other Outcome Measures ^ICMJE	Not Provided

Descriptive Information
Brief Title ^ICMJE	Bleeding Symptoms of Carriers of Hemophilia A and B
Official Title ^ICMJE	Bleeding Symptoms of Carriers of Hemophilia A and B
Brief Summary	To collect and analyze data on female carriers of severe and moderate hemophilia A and B.
Detailed Description	Not Provided
Study Type ^ICMJE	Observational
Study Design ^ICMJE	Observational Model: Cohort Time Perspective: Cross-Sectional
Target Follow-Up Duration	Not Provided
Biospecimen	Not Provided
Sampling Method	Non-Probability Sample
Study Population	Carriers of severe and moderate hemophilia A and B
Condition ^ICMJE	Hemophilia
Intervention ^ICMJE	Not Provided
Study Group/Cohort (s)	Not Provided
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Completed
Estimated Enrollment ^ICMJE	200
Completion Date	Not Provided
Primary Completion Date	Not Provided
Eligibility Criteria ^ICMJE	Inclusion Criteria: Female carriers of hemophilia A and B. Exclusion Criteria: Pregnancy.
Gender	Female
Ages	18 Years and older
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	Sweden

Administrative Information
NCT Number ^ICMJE	NCT01029808
Other Study ID Numbers ^ICMJE	VGAO002
Has Data Monitoring Committee	No
Responsible Party	Anna Olsson/MD, Department of hematology and coagulation, Sahlgrenska university hopsital
Study Sponsor ^ICMJE	Sahlgrenska University Hospital, Sweden
Collaborators ^ICMJE	Not Provided
Investigators ^ICMJE	Not Provided
Information Provided By	Sahlgrenska University Hospital, Sweden
Verification Date	July 2011
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top